Evidence map›Paper›PMID 39650229›Full record

ArticleOncology letters2025

Network pharmacology‑based analysis and

Xin-Xing Lin, Pei-Qing Yang, Xiao-Jun Li, Zhong-Zhen Xu, Hai-Tao Wu, Shun-Ming Hu, Xiao-Lei Yang, Yong Ding, Wei-Zhou Yu

Abstract read
In one paragraph

Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xin-Xing LinDepartment of General Surgery, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China.
Pei-Qing YangDepartment of Gastroenterology, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China.
Xiao-Jun LiDepartment of General Surgery, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China.
Zhong-Zhen XuDepartment of Gastroenterology, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China.
Hai-Tao WuDepartment of General Surgery, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China.
Shun-Ming HuDepartment of Gastroenterology, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China.
Xiao-Lei YangDepartment of General Surgery, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China.
Yong DingDepartment of General Surgery, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China.
Wei-Zhou YuDepartment of Gastroenterology, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate the inhibitory effect of luteoloside on the proliferation, migration and invasion of gastric cancer (GC) cells based on network pharmacology and

Indexed as

apoptosisgastric cancerluteolosidenetwork pharmacologyp53/p21 signaling pathway

Identifiers

PMID39650229
PMCPMC11622105

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.